Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 11 days ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago Regorafenib-Pembrolizumab Has 'Modest' Activity in HCC Post-Immunotherapy - 5 months ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - 10 months ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - 11 months ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - 12 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 12 months ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - 12 months ago Guselkumab for PsA Yields 'Meaningful Improvements' in Quality of Life - 12 months ago A Novel Mechanism of Action in Treating Relapsing MS - about 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago Guselkumab Shows Early Symptom Improvement in UC - about 1 year ago
2	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - 20 days ago Alternative Pathway Inhibition Makes Good in IgA Nephropathy - 22 days ago Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss - 5 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 8 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 12 months ago
3	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Myasthenia Gravis Patients May Use Less Steroids After Starting Efgartigimod - 28 days ago Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker - 29 days ago Continuous Parkinson's Disease Therapy Wins FDA Nod - about 1 month ago Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis - about 1 month ago S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS - about 1 year ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy - about 2 months ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 5 months ago Amgen’s trial brings new hope for IgG4-RD patients - 5 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 2 months ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 3 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago Year in Review: Follicular Lymphoma - 12 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer - about 1 year ago
6	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 2 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 11 months ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - about 1 year ago New Oral Drug Approved for Metastatic Colorectal Cancer - about 1 year ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 2 months ago FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 3 months ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 3 months ago FDA Approves Roflumilast for Atopic Dermatitis in Patients 6 Years and Older - 4 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 5 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 5 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 8 months ago FDA Grants Orphan Drug Designation to Felzartamab for Kidney Transplant Recipients - 8 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 9 months ago FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma - 9 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 11 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma - 12 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - about 1 year ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - about 1 year ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - about 1 year ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - about 1 year ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - 3 months ago FDA Grants Accelerated Approval of Resmetirom for Noncirrhotic Nonalcoholic Steatohepatitis With Moderate to Advanced Liver Fibrosis - 8 months ago
9	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Eli Lilly Shows Appetite for Oral Immunology Drugs, Swallowing Morphic in $3.2B Deal - 4 months ago Ipsen, Genfit Drug That Missed in MASH Wins FDA Approval in a Much Rarer Liver Disease - 5 months ago
10	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	J&J Submits sBLA To FDA for Guselkumab in Ulcerative Colitis - 8 months ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - about 1 year ago

Journalists covering fingolimod